← SynDRA
GARENOXACIN
SynDRA canonical compound SYN0006375 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | TOP2A |
|---|
| Mechanism of action | topoisomerase inhibitor |
|---|
| Indication | respiratory tract infections |
|---|
| Disease area | infectious disease |
|---|
All known targets
Mechanisms of action (all sources)
- topoisomerase inhibitor
- Inhibitor
Drug classes
- Anti-Bacterial Agents
- Anti-Infective Agents
- Antineoplastic Agents
- Enzyme Inhibitors
- Topoisomerase II Inhibitors
- Topoisomerase Inhibitors
ATC classes
- J01M · QUINOLONE ANTIBACTERIALS
Cross-references
Synonyms
- ganefloxacin
- garenfloxacin
- garenoxacin mesilate hydrate
- garenoxacin mesilate
- garenoxacin mesylate
- geninax
- Garenoxacine
- Garenoxacino
- T-3811
- T-3811MEa
- BMS 284756 (*Mesylate salt*)
- BMS-284756 (*Mesylate salt*);1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-(1-methyl-2,3-dihydro-1H-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
- 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxoquinoline-3-carboxylic acid
- T 3811
- garenoxacine
- garenoxacino
- garenoxacinum
- BMS284756
- Bms 284756
- V72H9867WB
- CHEBI:131716
- RefChem:142698
- DTXCID5095626
- J01MA19
- Ganefloxacin
- Garenfloxacin
- C23H20F2N2O4
- NCGC00181770-01
- Garenoxacin [INN:BAN]
- BMS-284756 (*Mesylate salt*)
- UNII-V72H9867WB
- Ganefl oxacin
- GARENOXACIN [MI]
- GARENOXACIN [INN]
- GARENOXACIN [MART.]
- GARENOXACIN [WHO-DD]
- orb1685515
- orb3025507
Look up GARENOXACIN in the interactive SynDRA portal →